Literature DB >> 27938430

Cognition as a treatment target in depression.

M Kaser1, R Zaman1, B J Sahakian1.   

Abstract

Cognitive dysfunction in depression is associated with poorer clinical outcomes and impaired psychosocial functioning. However, most treatments for depression do not specifically target cognition. Neurocognitive deficits such as memory and concentration problems tend to persist after mood symptoms recover. Improving cognition in depression requires a better understanding of brain systems implicated in depression. A comprehensive approach is warranted for refined methods of assessing and treating cognitive dysfunction in depression.

Entities:  

Keywords:  Cognition; depression; neuropsychological model; treatment target

Mesh:

Year:  2016        PMID: 27938430     DOI: 10.1017/S0033291716003123

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  13 in total

Review 1.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

Review 2.  Motivation and cognitive control in depression.

Authors:  Ivan Grahek; Amitai Shenhav; Sebastian Musslick; Ruth M Krebs; Ernst H W Koster
Journal:  Neurosci Biobehav Rev       Date:  2019-05-27       Impact factor: 8.989

3.  Predictors of Long-Term Improvement Following Cognitive Remediation in a Sample With Elevated Depressive Symptoms.

Authors:  Bjørn Ingulfsvann Hagen; Nils Inge Landrø; Bjørn Lau; Ernst H W Koster; Jan Stubberud
Journal:  Front Psychol       Date:  2020-09-11

4.  Cognitive performance in antidepressant-free recurrent major depressive disorder.

Authors:  Kimberly M Albert; Guy G Potter; Douglas R McQuoid; Warren D Taylor
Journal:  Depress Anxiety       Date:  2018-04-10       Impact factor: 6.505

5.  Associations between mentally-passive and mentally-active sedentary behaviours during adolescence and psychological distress during adulthood.

Authors:  André O Werneck; Erin Hoare; Brendon Stubbs; Esther M F van Sluijs; Kirsten Corder
Journal:  Prev Med       Date:  2021-01-22       Impact factor: 4.637

Review 6.  Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Authors:  Alexandria N Tartt; Madeline B Mariani; Rene Hen; J John Mann; Maura Boldrini
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

7.  Affective problems and decline in cognitive state in older adults: a systematic review and meta-analysis.

Authors:  A John; U Patel; J Rusted; M Richards; D Gaysina
Journal:  Psychol Med       Date:  2018-05-24       Impact factor: 7.723

8.  The Effect of Acute Aerobic Exercise on Divergent and Convergent Thinking and Its Influence by Mood.

Authors:  Kohei Aga; Masato Inamura; Chong Chen; Kosuke Hagiwara; Rikuto Yamashita; Masako Hirotsu; Tomoe Seki; Akiyo Takao; Yuko Fujii; Toshio Matsubara; Shin Nakagawa
Journal:  Brain Sci       Date:  2021-04-27

9.  Cognitive functioning and lifetime major depressive disorder in UK Biobank.

Authors:  Laura de Nooij; Mathew A Harris; Mark J Adams; Toni-Kim Clarke; Xueyi Shen; Simon R Cox; Andrew M McIntosh; Heather C Whalley
Journal:  Eur Psychiatry       Date:  2020-02-21       Impact factor: 5.361

10.  Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation.

Authors:  Golam M Khandaker; Bianca P Oltean; Muzaffer Kaser; Claire R M Dibben; Rajini Ramana; Deepak R Jadon; Robert Dantzer; Alasdair J Coles; Glyn Lewis; Peter B Jones
Journal:  BMJ Open       Date:  2018-09-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.